midazolam has been researched along with edetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Haitsma, JJ; Lachmann, B; Papadakos, PJ | 1 |
| Bi, XL; Chen, LT; Di, LQ; Du, Q; Zhou, W | 1 |
1 review(s) available for midazolam and edetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for midazolam and edetic acid
| Article | Year |
|---|---|
Additives in intravenous anesthesia modulate pulmonary inflammation in a model of LPS-induced respiratory distress.
Topics: Acute Lung Injury; Adjuvants, Anesthesia; Anesthesia, Intravenous; Animals; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Edetic Acid; Interleukin-6; Ketamine; Lipopolysaccharides; Midazolam; Propofol; Pulmonary Gas Exchange; Random Allocation; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Respiratory Distress Syndrome; Sulfites; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2009 |
[Intestinal absorption of forsythoside A by rat circulation in situ].
Topics: Animals; Colon; Cyclosporine; Digoxin; Dose-Response Relationship, Drug; Duodenum; Edetic Acid; Glycosides; Hydrogen-Ion Concentration; Ileum; Intestinal Absorption; Jejunum; Male; Mannitol; Midazolam; Rats; Rats, Sprague-Dawley | 2010 |